NDC11 00409030201
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00409-0302-01 | 00409-0302 |
| 00409-0302-1 | 00409-0302 |
| 00409-302-01 | 00409-302 |
| 0409-0302-01 | 0409-0302 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Topotecan | TOPOTECAN | Hospira, Inc. | 1d4e1cce-c57e-4a8b-be96-f95a2778e221 | 2021-02-01 | Boxed warning, Warnings, Adverse reactions | 0409-0302-01 0409-0302 00409030201 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.